PTC THERAPEUTICS INC (PTCT)       41.49  +1.14 (+2.83%)

41.49  +1.14 (+2.83%)

US69366J2006 - Common Stock - After market: 41.49 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 52.49. This target is 26.51% above the current price.
PTCT was analyzed by 20 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about PTCT.
In the previous month the buy percentage consensus was at a similar level.
PTCT was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 41.4936.3647.9452.4972.45 - -12.36% 15.55% 26.51% 74.62%

Up and Down Grades

Date Firm Action Rating
2022-10-28 RBC Capital Maintains Sector Perform
2022-10-28 Credit Suisse Maintains Neutral
2022-10-28 Morgan Stanley Maintains Equal-Weight
2022-10-17 RBC Capital Maintains Sector Perform
2022-09-12 Jefferies Initiate Buy
2022-09-09 Morgan Stanley Initiate Equal-Weight
2022-09-01 Citigroup Initiate Buy
2022-08-11 Raymond James Maintains Outperform
2022-06-23 RBC Capital Maintains Sector Perform
2022-02-23 Barclays Maintains Equal-Weight
2022-02-23 JP Morgan Maintains Overweight
2021-10-29 RBC Capital Maintains Sector Perform
2021-10-29 Raymond James Maintains Outperform
2021-10-29 Credit Suisse Maintains Neutral
2021-10-18 B of A Securities Downgrade Neutral -> Underperform
2021-07-30 Credit Suisse Maintains Neutral
2021-03-29 RBC Capital Upgrade Underperform -> Sector Perform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA